12th Mar 2021 14:11
RTW Venture Fund Ltd - investment company focused on the life sciences sector - Says Monte Rosa Therapeutics Inc has completed a USD95 million series C financing round. RTW Venture Fund confirms that it took part in the financing round together with other investment firms.
Monte Rosa is a preclinical-stage biotech company discovering and developing small molecule degraders to eliminate disease-causing proteins.
Current stock price: USDS2.30, down 3.0% on Friday
Year-to-date change: up 22%
By Evelina Grecenko; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Rtw Biotech